

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Malaria vaccines: facing unknowns | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-296/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-296" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Malaria vaccines: facing unknowns" />
    
            <meta name="og:title" content="F1000Research Article: Malaria vaccines: facing unknowns.">
            <meta name="og:description" content="Read the latest article version by Nirianne Marie Q. Palacpac, Toshihiro Horii, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="24419">
            <meta name="article-id" content="22143">
            <meta name="dc.title" content="Malaria vaccines: facing unknowns">
            <meta name="dc.description" content="Much of the gain in malaria control, in terms of regional achievements in restricting geographical spread and reducing malaria cases and deaths, can be attributed to large-scale deployment of antimalarial drugs, insecticide-treated bed nets, and early diagnostics. However, despite impressive progress, control efforts have stalled because of logistics, unsustainable delivery, or short-term effectiveness of existing interventions or a combination of these reasons. A highly efficacious malaria vaccine as an additional tool would go a long way, but success in the development of this important intervention remains elusive. Moreover, most of the vaccine candidate antigens that were investigated in early-stage clinical trials, selected partly because of their immunogenicity and abundance during natural malaria infection, were polymorphic or structurally complex or both. Likewise, we have a limited understanding of immune mechanisms that confer protection. We reflect on some considerable technological and scientific progress that has been achieved and the lessons learned.">
            <meta name="dc.subject" content="malaria, vaccine, Plasmodium">
            <meta name="dc.creator" content="Palacpac, Nirianne Marie Q.">
            <meta name="dc.creator" content="Horii, Toshihiro">
            <meta name="dc.date" content="2020/04/27">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.22143.1">
            <meta name="dc.source" content="F1000Research 2020 9:296">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="malaria">
            <meta name="prism.keyword" content="vaccine">
            <meta name="prism.keyword" content="Plasmodium">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/04/27">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="296">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.22143.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-296">
            <meta name="citation_title" content="Malaria vaccines: facing unknowns">
            <meta name="citation_abstract" content="Much of the gain in malaria control, in terms of regional achievements in restricting geographical spread and reducing malaria cases and deaths, can be attributed to large-scale deployment of antimalarial drugs, insecticide-treated bed nets, and early diagnostics. However, despite impressive progress, control efforts have stalled because of logistics, unsustainable delivery, or short-term effectiveness of existing interventions or a combination of these reasons. A highly efficacious malaria vaccine as an additional tool would go a long way, but success in the development of this important intervention remains elusive. Moreover, most of the vaccine candidate antigens that were investigated in early-stage clinical trials, selected partly because of their immunogenicity and abundance during natural malaria infection, were polymorphic or structurally complex or both. Likewise, we have a limited understanding of immune mechanisms that confer protection. We reflect on some considerable technological and scientific progress that has been achieved and the lessons learned.">
            <meta name="citation_description" content="Much of the gain in malaria control, in terms of regional achievements in restricting geographical spread and reducing malaria cases and deaths, can be attributed to large-scale deployment of antimalarial drugs, insecticide-treated bed nets, and early diagnostics. However, despite impressive progress, control efforts have stalled because of logistics, unsustainable delivery, or short-term effectiveness of existing interventions or a combination of these reasons. A highly efficacious malaria vaccine as an additional tool would go a long way, but success in the development of this important intervention remains elusive. Moreover, most of the vaccine candidate antigens that were investigated in early-stage clinical trials, selected partly because of their immunogenicity and abundance during natural malaria infection, were polymorphic or structurally complex or both. Likewise, we have a limited understanding of immune mechanisms that confer protection. We reflect on some considerable technological and scientific progress that has been achieved and the lessons learned.">
            <meta name="citation_keywords" content="malaria, vaccine, Plasmodium">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Nirianne Marie Q. Palacpac">
            <meta name="citation_author_institution" content="Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan">
            <meta name="citation_author" content="Toshihiro Horii">
            <meta name="citation_author_institution" content="Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan">
            <meta name="citation_publication_date" content="2020/04/27">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="296">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.22143.1">
            <meta name="citation_firstpage" content="296">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-296/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-296.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=24419 /> <input type=hidden id=articleId name=articleId value=22143 /> <input type=hidden id=xmlUrl value="/articles/9-296/v1/xml"/> <input type=hidden id=xmlFileName value="-9-296-v1.xml"> <input type=hidden id=article_uuid value=71e47577-724a-45f1-87a5-9043e13ab52a /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Malaria vaccines: facing unknowns"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.22143.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.22143.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-296"
  },
  "headline": "Malaria vaccines: facing unknowns",
  "datePublished": "2020-04-27T13:14:40",
  "dateModified": "2020-04-27T13:14:40",
  "author": [
    {
      "@type": "Person",
      "name": "Nirianne Marie Q. Palacpac"
    },    {
      "@type": "Person",
      "name": "Toshihiro Horii"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Much of the gain in malaria control, in terms of regional achievements in restricting geographical spread and reducing malaria cases and deaths, can be attributed to large-scale deployment of antimalarial drugs, insecticide-treated bed nets, and early diagnostics. However, despite impressive progress, control efforts have stalled because of logistics, unsustainable delivery, or short-term effectiveness of existing interventions or a combination of these reasons. A highly efficacious malaria vaccine as an additional tool would go a long way, but success in the development of this important intervention remains elusive. Moreover, most of the vaccine candidate antigens that were investigated in early-stage clinical trials, selected partly because of their immunogenicity and abundance during natural malaria infection, were polymorphic or structurally complex or both. Likewise, we have a limited understanding of immune mechanisms that confer protection. We reflect on some considerable technological and scientific progress that has been achieved and the lessons learned."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-296.html",
            "name": "Malaria vaccines: facing unknowns"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Malaria vaccines: facing unknowns </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=24419 data-id=22143 data-downloads="" data-views="" data-scholar="10.12688/f1000research.22143.1" data-recommended="" data-doi="10.12688/f1000research.22143.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-296/v1/pdf?article_uuid=71e47577-724a-45f1-87a5-9043e13ab52a" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-22143-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-22143-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-22143-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Palacpac NMQ and Horii T. Malaria vaccines: facing unknowns [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):296 (<a class=new-orange href="https://doi.org/10.12688/f1000research.22143.1" target=_blank>https://doi.org/10.12688/f1000research.22143.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-22143-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=22143 id=track-article-signin-22143 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/22143?target=/articles/9-296.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=24419 /> <input name=articleId type=hidden value=22143 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Malaria vaccines: facing unknowns</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:nirian@biken.osaka-u.ac.jp" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Nirianne Marie Q. Palacpac</span></a><a href="https://orcid.org/0000-0003-4098-3972" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4098-3972</div>,&nbsp;</span><span class="">Toshihiro Horii</span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:nirian@biken.osaka-u.ac.jp" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Nirianne Marie Q. Palacpac</span></a><a href="http://orcid.org/0000-0003-4098-3972" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4098-3972</div>,&nbsp;</span><span class="">Toshihiro Horii</span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 27 Apr 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.22143.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan<br/> <p> <div class=margin-bottom> Nirianne Marie Q. Palacpac <br/> <span>Roles: </span> Conceptualization, Resources, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Toshihiro Horii <br/> <span>Roles: </span> Conceptualization, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=37071-62555></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=66648-62554></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Much of the gain in malaria control, in terms of regional achievements in restricting geographical spread and reducing malaria cases and deaths, can be attributed to large-scale deployment of antimalarial drugs, insecticide-treated bed nets, and early diagnostics. However, despite impressive progress, control efforts have stalled because of logistics, unsustainable delivery, or short-term effectiveness of existing interventions or a combination of these reasons. A highly efficacious malaria vaccine as an additional tool would go a long way, but success in the development of this important intervention remains elusive. Moreover, most of the vaccine candidate antigens that were investigated in early-stage clinical trials, selected partly because of their immunogenicity and abundance during natural malaria infection, were polymorphic or structurally complex or both. Likewise, we have a limited understanding of immune mechanisms that confer protection. We reflect on some considerable technological and scientific progress that has been achieved and the lessons learned. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> malaria, vaccine, Plasmodium </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Nirianne Marie Q. Palacpac (<a href="mailto:nirian@biken.osaka-u.ac.jp">nirian@biken.osaka-u.ac.jp</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Nirianne Marie Q. Palacpac </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Palacpac NMQ and Horii T. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Palacpac NMQ and Horii T. Malaria vaccines: facing unknowns [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):296 (<a href="https://doi.org/10.12688/f1000research.22143.1" target=_blank>https://doi.org/10.12688/f1000research.22143.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 27 Apr 2020, <b>9</b>(F1000 Faculty Rev):296 (<a href="https://doi.org/10.12688/f1000research.22143.1" target=_blank>https://doi.org/10.12688/f1000research.22143.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 27 Apr 2020, <b>9</b>(F1000 Faculty Rev):296 (<a href="https://doi.org/10.12688/f1000research.22143.1" target=_blank>https://doi.org/10.12688/f1000research.22143.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e142>Introduction</h2><p class="" id=d5599e145><i>Plasmodium</i> protozoan parasites <i>P. falciparum</i>, <i>P. vivax</i>, <i>P. ovale</i> (<i>P. ovale curtisi</i> and <i>P. ovale wallikeri</i>), <i>P. malariae</i>, and <i>P. knowlesi</i> can infect humans. <i>P. falciparum</i> is responsible for the majority of malaria-attributable deaths, and the global malaria burden is borne disproportionally by children in sub-Saharan Africa<sup><a href="#ref-1">1</a></sup>. Malaria symptoms range from severe headaches, chills, joint pain, and fever-like symptoms to red blood cell dysregulation and lysis that can lead to severe anemia, sequestration of infected red blood cells, or occlusion. Occlusion can lead to cerebral malaria or complications associated with placental malaria, including adverse birth outcomes with long-term sequelae or death.</p><p class="" id=d5599e179>Vaccines for malaria aim to either eliminate/prevent infection (for example, in the liver or blood or they interrupt transmission in mosquitoes) or control/limit parasite growth/multiplication and duration of infection<sup><a href="#ref-2">2</a></sup>. Approaches to malaria vaccine development have ranged from traditional (live-attenuated or killed) to subunit (single-antigen recombinant proteins that target the various stages in the parasite life cycle) vaccines to newer approaches targeting the inclusion of only defined antigenic regions or critical epitopes<sup><a href="#ref-2">2</a>–<a href="#ref-4">4</a></sup>. The struggle continues to develop a vaccine to protect people from this disease.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e196>Burden and current interventions</h2><p class="" id=d5599e199>More than 90% of the sub-Saharan Africa population live in malaria-endemic areas<sup><a href="#ref-1">1</a>,<a href="#ref-5">5</a></sup>. In Africa, 99.7% of estimated malaria cases are due to <i>P. falciparum</i><sup><a href="#ref-1">1</a></sup>. Outside of Africa, <i>P. vivax</i> accounts for most of the disease burden: 73% in the World Health Organization (WHO) Region of the Americas and 53% in the WHO Southeast Asia Region<sup><a href="#ref-1">1</a></sup>. <i>P. vivax</i> burden is difficult to assess as infections can cause relapse months or years after initial infection because of the persistence of hypnozoites in hepatocytes. Other species represent a small proportion globally. <i>P. ovale</i> and <i>P. malariae</i> are common sympatric species in malaria-endemic regions<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. Data on the global burden of <i>P. knowlesi</i>, a zoonotic parasite, are much less known. Nevertheless, this species has been reported to cause severe human malaria and is important for certain populations in Indonesia, the Philippines, Cambodia, South Thailand, South Myanmar, and South Vietnam<sup><a href="#ref-8">8</a>–<a href="#ref-10">10</a></sup>.</p><p class="" id=d5599e249>The WHO World Malaria Report<sup><a href="#ref-1">1</a></sup> and high-resolution maps for <i>P. falciparum</i><sup><a href="#ref-5">5</a></sup> and <i>P. vivax</i><sup><a href="#ref-11">11</a></sup> capture the considerable progress in reducing malaria burden and the stall in the rates of decline in recent years. In a handful of developed countries, control efforts were aided greatly by successful economic development, improved health-care systems, and urbanization<sup><a href="#ref-5">5</a></sup>. But in resource-poor settings, gains achieved are noted as fragile, relying on a limited number of interventions: insecticide-treated bed nets, indoor residual spraying, artemisinin combination therapy, intermittent preventive treatment, and increased access to diagnostic testing<sup><a href="#ref-12">12</a></sup>. Moreover, bottlenecks and gaps for optimal coverage exist because of less sensitive tools and infection/disease management; for example, pregnant women are possible reservoirs that sustain malaria transmission, and pyrimethamine is contraindicated in the first trimester<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>. The campaign for increased annual funding, from US $2.7 billion to US $6.4 billion, for investments that aimed to meet a 40% reduction in malaria incidence and mortality rates remains challenging<sup><a href="#ref-15">15</a></sup>. For vector control, four commonly used insecticide classes are already in widespread use in Africa, the Americas, Southeast Asia, the Eastern Mediterranean, and the Western Pacific, raising warning bells for a possible emergence of insecticide resistance<sup><a href="#ref-12">12</a></sup>. The same is true for antimalarial drugs. At present, there are only three major/broad categories of available antimalarials. Poor quality, incomplete treatment, and misuse (including continued use of artemisinin-based monotherapy) could result to development and spread of drug-resistant parasites. Fortunately, to date, no evidence for substantial drug resistance has been documented<sup><a href="#ref-16">16</a>–<a href="#ref-18">18</a></sup>. However, the Global Technical Strategy for Malaria 2016–2030 milestones<sup><a href="#ref-15">15</a></sup>, to reduce malaria incidence and mortality by at least 40% in 2020, cannot be attained with current tools.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e306>Malaria vaccines</h2><p class="" id=d5599e309>By experience, vaccines are among the most successful and cost-effective public health tools. Millions of lives have been saved and a substantial reduction in morbidity has been associated with vaccine scale-up implementation against other diseases. A case in point would be the recent vaccine implementation of meningococcal vaccine in sub-Saharan Africa<sup><a href="#ref-19">19</a></sup>. A malaria vaccine, if implemented through the routine/existing immunization delivery programmes, such as the Expanded Programme on Immunization (EPI), could have more reaching coverage logistically and improved compliance (compared with traditional antimalarial prophylaxis) and would help close the gap left by other control measures. However, considerations for inclusion to the EPI also need validation in field trials. Co-administration of a candidate tuberculosis vaccine, MVA85A, with EPI vaccines resulted in lowered tuberculosis-specific immunogenicity<sup><a href="#ref-20">20</a></sup>. On the other hand, with the pre-erythrocytic malaria vaccine—chimpanzee adenovirus 63 and modified vaccinia virus Ankara encoding multiple epitope string thrombospondin-related adhesion protein (ChAd63 MVA ME-TRAP)—antibody responses to EPI vaccines were not altered in a phase Ib trial<sup><a href="#ref-21">21</a></sup>. Both studies underscore the importance of optimal schedules and timing of immunizations for testing in clinical trials as well as for actual vaccine implementation.</p><p class="" id=d5599e324>A number of vaccines in the malaria pipeline have similar challenges/limitations due in part to the complex biology and life cycle of <i>Plasmodium</i> and the immunological interplay between the parasite and host. At the same time, every malaria infection can be considered unique in terms of antigenic repertoire and host, frequency of exposure, age, access to treatment, and presence of co-morbidities. Three recent reviews summarize vaccines now in development<sup><a href="#ref-2">2</a>–<a href="#ref-4">4</a></sup>. RTS,S (registered as Mosquirix), based on the circumsporozoite protein, is thus far the only vaccine that has progressed beyond phase 3 and is now in a WHO-recommended and -sponsored pilot implementation program complementing a GlaxoSmithKline-sponsored phase 4 trial<sup><a href="#ref-2">2</a></sup>. RTS,S is a pre-erythrocytic vaccine directed at the sporozoite stage or at the infected hepatocyte. The vaccine, in theory, should prevent blood-stage infection but, in reality, proved to be “leaky”<sup><a href="#ref-22">22</a></sup>. The pilot implementation of RTS,S aims (a) to address whether the protection demonstrated in the 5- to 17-month old multicenter phase 3 trial can be replicated in the context of routine health systems with a four-dose schedule and to evaluate (b) the excess risk of febrile seizures observed within 7 days after a vaccine dose, (c) the number of meningitis cases, (d) the number of cerebral malaria cases in the malaria vaccine group compared with the control, and (e) the imbalance of mortality among girls who received the vaccine<sup><a href="#ref-23">23</a></sup>. The Joint Technical Expert Group (JTEG) on malaria vaccines also recommended monitoring the emergence of vaccine resistance strains and testing of alternative schedules and other strategies to improve the efficacy of RTS,S. The JTEG noted that, if safety concerns are resolved and favorable implementation data become available, the WHO can recommend country-wide introduction. Projection for RTS,S shows that if it is implemented in all 43 malaria-endemic countries in sub-Saharan Africa, 123 million (95% prediction interval, 117 to 129 million) malaria episodes over the first 10 years could be averted<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d5599e354>Indeed, the RTS,S experience is a learning curve for all other malaria vaccines in the pipeline. Of note, the concern about a possible negative effect on overall female mortality may indeed be valid and needs careful consideration since this finding was observed in both age groups<sup><a href="#ref-25">25</a></sup> and in a number of vaccines<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>. Similar obstacles and lessons provide much hope, rather than pessimism, as we move forward in addressing some key challenges.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e371>Polymorphism</h2><p class="" id=d5599e374>As in other vaccine candidates, polymorphism abrogates antigen recognition. On the other hand, conserved important epitopes are generally poorly immunogenic. In RTS,S, the dominant epitope recognized by antibodies—(NANP)n from the circumsporozoite protein (CSP)—is totally conserved in <i>P. falciparum</i> but the T-cell (as well as B-cell) epitopes are known to be polymorphic<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. A number of other vaccine candidates did not show much promise after efficacy trials suggested strain-specific protection<sup><a href="#ref-2">2</a>–<a href="#ref-4">4</a></sup>. In fact, the lack of success in developing subunit blood-stage vaccine candidates and lack of cross-stage immunity were among the driving factors to develop whole parasite vaccines (WPVs). WPV supposes that no individual parasite protein can be sufficient to induce strain-transcending immunity and that, aside from antibodies, B and T cells also play a role. WPVs aimed to maximize antigen breadth, although, whether irradiated parasites, genetically attenuated parasites, chemically attenuated parasites or killed parasites, the vaccine pathway represents a significant challenge because of difficulties in vaccine manufacture and specific regulatory issues<sup><a href="#ref-28">28</a></sup>. So far, clinical trials have shown that WPVs are well tolerated in terms of reactogenicity<sup><a href="#ref-2">2</a></sup>. The presence of extraneous (possible toxins, pathogens, and contaminants) materials not essential for the generation of protective immune response as well as concerns on vaccine route, dose, and regimen are being addressed<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a>,<a href="#ref-28">28</a></sup>.</p><p class="" id=d5599e413>Other innovations in antigen discovery have now come up with an extensive list of potential antigens from genomic-, proteomic-, and transcriptomic-based approaches<sup><a href="#ref-29">29</a>–<a href="#ref-32">32</a></sup>. Similar to vaccine development against viral infections such as human immunodeficiency virus and influenza, structure-guided vaccine design is currently tapped to identify protective/functional and non-functional epitopes in antigen–antibody complexes<sup><a href="#ref-33">33</a>–<a href="#ref-35">36</a></sup>. With difficulties for representative <i>in vitro</i> models, structure-guided vaccine design has also been used to inform the development of at least the most promising vaccine candidate for <i>P. vivax</i>, the <i>Pv</i> Duffy-binding protein<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>.</p><p class="" id=d5599e447>These innovations have, likewise, pushed antigen delivery platforms. Since subunit vaccines based on soluble recombinant proteins are often poorly immunogenic, the use of virus capsid-like particle vaccine platforms is beginning in the malaria field<sup><a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>. Virus-like particles (VLPs), when overexpressed, spontaneously self-assemble into particles that are highly immunogenic because of their structural resemblance to original live viruses<sup><a href="#ref-39">39</a>–<a href="#ref-43">43</a></sup>. A direct comparison of three VLP platforms for a transmission-blocking vaccine<sup><a href="#ref-44">44</a></sup> showed that high quantity and quality of antibodies with minimal reactogenicity could be achieved.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e471>Poor understanding of vaccine-induced immune response</h2><p class="" id=d5599e474>To date, we still have a considerable lack of understanding in the immunological mechanisms that provide protection against malaria, including what immune responses are induced in people who are protected and in people who are not. Immune correlates of protection are known to exist for successful vaccines. This knowledge can permit licensure of new vaccine formulations or extension of vaccine indications to new populations on the basis of immunogenicity endpoints<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>. In some cases, evaluations are restricted to antibody titers and a few basic T-cell analyses: cytokine-ELISpot or interferon-gamma, interleukin-2 (IL-2), or tumor necrosis factor-alpha (TNFα) readouts or a combination of these. Hepatitis B vaccine testing was simplified when it was shown that hepatitis B S antigen antibodies of more than 10 mIU/mL were surrogate markers of protection<sup><a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>. Interestingly, a recent study also showed the utility of T-cell (TNFα, IL-10, or IL-6) responses 32 years after vaccination despite the absence of detectable anti-hepatitis B antibodies<sup><a href="#ref-49">49</a></sup>. The cellular responses provided insight on how to evaluate long-term immunity; even under natural exposure, no breakthrough hepatitis B virus (HBV) infection was recorded<sup><a href="#ref-49">49</a></sup>, suggesting that the immune response can be boosted to prevent acute illness and chronic HBV infection.</p><p class="" id=d5599e499>In malaria, antibody titers and T-cell responses showed limited correlation and have largely failed to predict vaccine efficacy (VE) or down-select vaccine formulations prior to late-stage, large trials<sup><a href="#ref-50">50</a></sup>. In RTS,S, antibody titer concentrations of 121 enzyme-linked immunosorbent assay units per milliliter (95% confidence interval [CI] 98–153) prevented 50% of infection, but no threshold level for protection was found in the phase 3 trial<sup><a href="#ref-51">51</a></sup>. Further review of previous trials also showed that a modification of dose and schedule improved vaccine protection: 62% of volunteers (10/16) given the full dose at the standard 0-, 1-, 2-month regimen were protected 3 weeks after the last vaccination, whereas 86% of volunteers (26/30) were protected when the third dose occurred 6 months after the second and the dose was reduced to one fifth of the original dose (known as fractional dosing<sup><a href="#ref-52">52</a></sup>). With a fractional dose, titers of anti-NANP antibody were similar to subjects vaccinated using standard regimen, and it was speculated that the altered dosing had an effect on antibody avidity, somatic hypermutation, and isotype switching<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. The roles of CD4<sup>+</sup> T-cell responses have been suggested but remained inconsistent<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>, although it cannot be denied that protection is indeed mediated by complex immune functions. The inability to maintain high antibody titer after vaccination also needs in-depth studies<sup><a href="#ref-51">51</a></sup>. Waning or duration of immunity remains an important question as current vaccine candidates still have to demonstrate an acceptable duration of protection so that frequent revaccination is not necessary.</p><p class="" id=d5599e536>Besides antibody responses, CD4 and T cells have also been implicated in the WPV, PfSPZ<sup><a href="#ref-56">56</a></sup>. The absence of a T-cell response in 6- to 11-month-old vaccinees was interpreted to mean that there will be no protection for this age group by using the current PfSPZ immunization regimen (three doses at 8-week intervals). For blood-stage vaccine GMZ2/alum, a phase 2 efficacy trial showed higher VE in children 3 to 4 years old (VE = 20%, 95% CI 4–33%) than in children 1 to 2 years old (VE = 14%, 95% CI 3.6–23%)<sup><a href="#ref-57">57</a></sup>. It was concluded that, compared with toddlers, the older children have antibodies that were more functionally competent in terms of avidity and IgG subclass profile. Acquired background immunity to malaria would have helped the older cohort.</p><p class="" id=d5599e547>There is general agreement that effective assessment of induced immune response needs unbiased, comprehensive profiling together with mathematical modelling/computational analyses. Such methods can capture the overall picture/combination effects of multiple immune responses<sup><a href="#ref-45">45</a>,<a href="#ref-58">58</a>,<a href="#ref-59">59</a></sup>. Robust screening assays to assess protective potential or detect non-direct inhibitory or neutralizing activity of antibodies or assays that capture antibody-complement interactions and their consequences to parasite function and viability are most important considerations. For meningococcal vaccines, the availability of the serum bactericidal antibody assay, which measures complement-mediated killing via functional antibody concentrations, has proven to be a valuable tool<sup><a href="#ref-60">60</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e568>Controlled human malaria infection</h2><p class="" id=d5599e571>The licensing by US Food and Drug Administration of a live, oral cholera vaccine (Vaxchora) for use in travelers on the basis of controlled human infection model in volunteers 18 to 64 years of age raised hopes that a malaria vaccine for travelers could also utilize human challenge data and pass along the same regulatory approach for licensure<sup><a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>. Clearly, controlled human malaria infection (CHMI) is a powerful tool (a) to provide early-stage proof-of-concept efficacy for vaccine candidates and (b) to address the limitation of preclinical testing in mice and non-human primates to predict immune response and to study mechanisms of protective immunity<sup><a href="#ref-63">63</a>,<a href="#ref-64">64</a></sup>. Because this experimental model allows some homogeneity/control of parasitemia within and between treatment arms, a major advantage is the relatively small sample size required for the evaluation of VE. The model is also ideally useful to advance field trials of transmission-blocking vaccines<sup><a href="#ref-65">65</a></sup>. In addition, it is less restrictive to have access to blood samples for antibody and T-cell work, allowing in-depth studies.</p><p class="" id=d5599e592>So far, only RTS,S<sup><a href="#ref-55">55</a></sup>, chemoattenuated <i>P. falciparum</i> sporozoite vaccine<sup><a href="#ref-66">66</a></sup>, whole parasite immunization under chloroquine drug cover<sup><a href="#ref-67">67</a></sup>, and whole sporozoite radiation-attenuated vaccines<sup><a href="#ref-68">68</a></sup> were able to induce sterile immunity in a significant proportion of human volunteers. CHMI was used by RTS,S to test for various formulations, adjuvants, and vaccine timings<sup><a href="#ref-52">52</a>,<a href="#ref-55">55</a>,<a href="#ref-64">64</a></sup>. The <i>P. vivax</i> CHMI model has been used successfully to test the efficacy of radiation-attenuated sporozoites administered by mosquito bite<sup><a href="#ref-69">69</a></sup>.</p><p class="" id=d5599e632>CHMI has been harnessed to identify the range and specificities of antibody responses and antigen targets<sup><a href="#ref-70">70</a></sup> as well as down-select other vaccine candidates<sup><a href="#ref-71">71</a></sup>. Currently, five challenge strains are available for CHMI use<sup><a href="#ref-72">72</a>–<a href="#ref-75">75</a></sup>. This is important, as it is necessary to address the regulatory concern of strain-transcending protective efficacy or cross-strain protection. All strains so far show global geographic differences in genetic variation<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a>,<a href="#ref-75">75</a></sup>; however, how representative they are of the overall diversity of <i>P. falciparum</i> field population remains to be seen. Efforts are ongoing to increase familiarity on the restrictions and challenges of CHMI models to regulators to determine the feasibility to accept these trials as part of the regulatory package for licensure<sup><a href="#ref-63">63</a>,<a href="#ref-64">64</a>,<a href="#ref-76">76</a>,<a href="#ref-77">77</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e680>Low-level parasite infection and immune tolerance</h2><p class="" id=d5599e683>Low-level parasite infection confuse diagnostics/detection or attribution of symptom/fever to malaria and raise the question of how the chronic nature of malaria infection (persistent parasite infection) amplifies or down-regulates immune response. B-cell hypo-responsiveness as a result of meningococcal and polysaccharide vaccines has been reported<sup><a href="#ref-78">78</a></sup>. Many clinical trials suggest that pre-existing immunity induced immune tolerance, resulting in lower immunogenicity and efficacy in African adults and malaria-exposed children<sup><a href="#ref-79">79</a>–<a href="#ref-82">82</a></sup>. The picture becomes more complicated when host genetics, access to treatment, and co-infection are considered. Performing studies to assess these confounding/contributory variables in vaccine trials are needed.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e700>Vaccine efficacy in clinical trials</h2><p class="" id=d5599e703>Endpoints and assessment methods to measure VE in clinical trials also lack clear consensus. In malaria-endemic areas, the rate of acquisition of natural immunity will vary between individuals; even within a country, malaria parasite transmission differs per site depending on climate/season and breeding sites. These factors affect the clinical trial design, surveillance methods, follow-up, and size of cohort. With RTS,S, during clinical trials, VE was evaluated by measuring time to first infection since natural infection is present in malaria-endemic areas and there is no control of time or amount of exposure to malaria in the different subjects. However, the WHO/JTEG specifically requested that all vaccine efficacies be reported against all episodes of the outcome (not only first or only episode) to better reflect the public health contribution of the vaccine. And what about boosting? Boosting through natural infection appears to be an important contributor in reducing the multiplicity of malaria episodes, especially for the blood-stage vaccine, SE36<sup><a href="#ref-83">83</a></sup>. Of note, not all infections are clinically important (or manifest as clinical symptoms) and this complicates predictions for exposure, risk, and protective efficacy.</p><p class="" id=d5599e710>Vaccines aimed against malaria sporozoites might lead to a delayed acquisition of natural immunity, resulting in increased risk of malaria when the protection afforded by vaccination has waned compared with individuals who did not receive the vaccine. This was observed in other malaria interventions such as weekly malaria chemoprophylaxis and use of insecticide-treated bed nets. The phenomenon has been termed rebound malaria<sup><a href="#ref-84">84</a>,<a href="#ref-85">85</a></sup>. An additional three years of follow-up showed that RTS,S/AS01 vaccination might lead to periods of increased risk to uncomplicated malaria when vaccine-induced protection has waned<sup><a href="#ref-85">85</a></sup>. This observation is in line with the previous phase 2 study carried out in Kenya, where the initial protection provided by three RTS,S/AS01 doses was offset by rebound after five years in areas with higher-than-average exposure to malaria parasites<sup><a href="#ref-86">86</a></sup>. Three-year extension of the phase 3 trial in Nanoro, Burkina Faso showed an increase in clinical malaria incidence in the RTS,S vaccinees when the children were older. Nevertheless, the rebound was not outweighed by the initial benefit and there was no increased risk for severe malaria or a shift toward cerebral malaria<sup><a href="#ref-85">85</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e735>Novel adjunctive tools</h2><p class="" id=d5599e738>Another important question that research would want to address is how to achieve and maintain stronger and longer-lasting VE through the use of adjuvants or optimal dose/delivery methods or both. An appropriate adjuvant will greatly increase the immunogenicity of a vaccine<sup><a href="#ref-58">58</a>,<a href="#ref-87">87</a>–<a href="#ref-90">90</a></sup>. Vaccine adjuvants have been tapped to target innate immune responses, activate the Toll-like receptor signaling pathway, and expand the antibody repertoire against the malaria parasite. Studies for novel and more effective human-compatible adjuvant to improve vaccine response are ongoing.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e754>Summary and Conclusions</h2><p class="" id=d5599e757>Efforts to come up with efficacious malaria vaccine continue despite challenges. As new approaches (use of structural epitopes for antigen selection; development of novel vectors, adjuvants, and delivery methods; altered vaccine schedules and dosages; utilization of new tools) lend themselves to malaria research, a cooperative global effort should also be established to allow various vaccine candidates in the developmental pipeline to be compared side by side in proof-of-concept clinical trials to overcome most of the financial challenge in investing in large-scale good manufacturing practice (GMP) production, phase III and IV studies. It has become generally accepted that likely combinations of effective vaccines that complement each other will be used, and a successful vaccine must be able to induce both humoral and T-cell responses. But the efficacy of each vaccine component needs to be evaluated, or a hit-and-miss approach will entail extensive investment. The burden of developing a malaria vaccine is currently spread to only a few partners reluctant to invest as more candidates are discovered and innovations are made in delivery, yet there are knowledge gaps in the candidates’ mechanism/correlates of protection and undefined regulatory pathway(s). A collaborative effort is especially important to be initiated from the scientific community given that primary target groups are those in low- and middle-income countries. Finally, as illustrated above, most available data come from studies of <i>P. falciparum</i>, and studies on <i>P. vivax</i> are also needed to help advance vaccines that will contribute to malaria elimination.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5599e769>Acknowledgments</h2><p class="" id=d5599e772>Authors thank their many collaborators—Sophie Houard and European Vaccine Initiative, Sodiomon B. Sirima and his team (Groupe de Recherche Action en Santé), Nobelpharma Co. Ltd.—for their ideas, motivation, and tenacity. An efficacious malaria vaccine can be achieved!</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d5599e779 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d6203>References</h2><div class="section ref-list"><a name=d5599e779 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d5599e786 class=n-a></a>World Malaria Report 2019. Geneva: World Health Organization; Licence: CC BY-NC-SA 3.0 IGO. 2019. <a target=xrefwindow id=d5599e788 href="https://www.who.int/publications-detail/world-malaria-report-2019">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d5599e797 class=n-a></a>Draper SJ, Sack BK, King CR, <i> et al.</i>: Malaria Vaccines: Recent Advances and New Horizons. <i>Cell Host Microbe.</i> 2018; <b>24</b>(1): 43–56. <a target=xrefwindow id=d5599e808 href="http://www.ncbi.nlm.nih.gov/pubmed/30001524">PubMed Abstract </a> | <a target=xrefwindow id=d5599e811 href="https://doi.org/10.1016/j.chom.2018.06.008">Publisher Full Text </a> | <a target=xrefwindow id=d5599e815 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6054918">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d5599e824 class=n-a></a>Zheng J, Pan H, Gu Y, <i> et al.</i>: Prospects for Malaria Vaccines: Pre-Erythrocytic Stages, Blood Stages, and Transmission-Blocking Stages. <i>Biomed Res Int.</i> 2019; <b>2019</b>: 9751471. <a target=xrefwindow id=d5599e835 href="http://www.ncbi.nlm.nih.gov/pubmed/31687404">PubMed Abstract </a> | <a target=xrefwindow id=d5599e838 href="https://doi.org/10.1155/2019/9751471">Publisher Full Text </a> | <a target=xrefwindow id=d5599e842 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6794966">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d5599e851 class=n-a></a>Salamanca DR, Gómez M, Camargo A, <i> et al.</i>: <i>Plasmodium falciparum</i> Blood Stage Antimalarial Vaccines: An Analysis of Ongoing Clinical Trials and New Perspectives Related to Synthetic Vaccines. <i>Front Microbiol.</i> 2019; <b>10</b>: 2712. <a target=xrefwindow id=d5599e865 href="http://www.ncbi.nlm.nih.gov/pubmed/31849871">PubMed Abstract </a> | <a target=xrefwindow id=d5599e869 href="https://doi.org/10.3389/fmicb.2019.02712">Publisher Full Text </a> | <a target=xrefwindow id=d5599e872 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6901501">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d5599e881 class=n-a></a>Weiss DJ, Lucas TCD, Nguyen M, <i> et al.</i>: Mapping the global prevalence, incidence, and mortality of <i>Plasmodium falciparum</i>, 2000-17: a spatial and temporal modelling study. <i>Lancet.</i> 2019; <b>394</b>(10195): 322–31. <a target=xrefwindow id=d5599e895 href="http://www.ncbi.nlm.nih.gov/pubmed/31229234">PubMed Abstract </a> | <a target=xrefwindow id=d5599e899 href="https://doi.org/10.1016/S0140-6736(19)31097-9">Publisher Full Text </a> | <a target=xrefwindow id=d5599e902 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6675740">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d5599e912 class=n-a></a>Yman V, Wandell G, Mutemi DD, <i> et al.</i>: Persistent transmission of <i>Plasmodium malariae</i> and <i>Plasmodium ovale</i> species in an area of declining <i>Plasmodium falciparum</i> transmission in eastern Tanzania. <i>PLoS Negl Trop Dis.</i> 2019; <b>13</b>(5): e0007414. <a target=xrefwindow id=d5599e933 href="http://www.ncbi.nlm.nih.gov/pubmed/31136585">PubMed Abstract </a> | <a target=xrefwindow id=d5599e936 href="https://doi.org/10.1371/journal.pntd.0007414">Publisher Full Text </a> | <a target=xrefwindow id=d5599e939 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6555537">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727237188"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e948 class=n-a></a>Rutledge GG, Böhme U, Sanders M, <i> et al.</i>: <i>Plasmodium malariae</i> and <i>P. ovale</i> genomes provide insights into malaria parasite evolution. <i>Nature.</i> 2017; <b>542</b>(7639): 101–4. <a target=xrefwindow id=d5599e966 href="http://www.ncbi.nlm.nih.gov/pubmed/28117441">PubMed Abstract </a> | <a target=xrefwindow id=d5599e969 href="https://doi.org/10.1038/nature21038">Publisher Full Text </a> | <a target=xrefwindow id=d5599e972 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5326575">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727237188">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d5599e985 class=n-a></a>Moyes CL, Henry AJ, Golding N, <i> et al.</i>: Defining the geographical range of the <i>Plasmodium knowlesi</i> reservoir. <i>PLoS Negl Trop Dis.</i> 2014; <b>8</b>(3): e2780. <a target=xrefwindow id=d5599e999 href="http://www.ncbi.nlm.nih.gov/pubmed/24676231">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1003 href="https://doi.org/10.1371/journal.pntd.0002780">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1006 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3967999">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d5599e1015 class=n-a></a>Singh B, Daneshvar C: Human infections and detection of <i>Plasmodium knowlesi</i>. <i>Clin Microbiol Rev.</i> 2013; <b>26</b>(2): 165–84. <a target=xrefwindow id=d5599e1026 href="http://www.ncbi.nlm.nih.gov/pubmed/23554413">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1029 href="https://doi.org/10.1128/CMR.00079-12">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1033 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3623376">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d5599e1042 class=n-a></a>Fornace KM, Brock PM, Abidin TR, <i> et al.</i>: Environmental risk factors and exposure to the zoonotic malaria parasite <i>Plasmodium knowlesi</i> across northern Sabah, Malaysia: a population-based cross-sectional survey. <i>The Lancet Planetary Health.</i> 2019; <b>3</b>(4): e179–e186. <a target=xrefwindow id=d5599e1056 href="http://www.ncbi.nlm.nih.gov/pubmed/31029229">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1060 href="https://doi.org/10.1016/S2542-5196(19)30045-2">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1063 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6484808">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d5599e1072 class=n-a></a>Battle KE, Lucas TCD, Nguyen M, <i> et al.</i>: Mapping the global endemicity and clinical burden of <i>Plasmodium vivax</i>, 2000–17: a spatial and temporal modelling study. <i>Lancet.</i> 2019; <b>394</b>(10195): 332–343. <a target=xrefwindow id=d5599e1086 href="http://www.ncbi.nlm.nih.gov/pubmed/31229233">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1090 href="https://doi.org/10.1016/S0140-6736(19)31096-7">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1093 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6675736">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d5599e1103 class=n-a></a>Compendium of WHO malaria guidance – prevention, diagnosis, treatment, surveillance and elimination: Geneva: World Health Organization; Licence: CC BY-NC-SA 3.0 IGO. 2019. <a target=xrefwindow id=d5599e1105 href="https://www.who.int/malaria/publications/atoz/compendium/en/">Reference Source</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d5599e1114 class=n-a></a>Moore KA, Simpson JA, Scoullar MJL, <i> et al.</i>: Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis. <i>Lancet Glob Health.</i> 2017; <b>5</b>(11): e1101–e1112. <a target=xrefwindow id=d5599e1125 href="http://www.ncbi.nlm.nih.gov/pubmed/28967610">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1128 href="https://doi.org/10.1016/S2214-109X(17)30340-6">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732604977"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1137 class=n-a></a>Rogerson SJ, Desai M, Mayor A, <i> et al.</i>: Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. <i>Lancet Infect Dis.</i> 2018; <b>18</b>(4): e107–e118. <a target=xrefwindow id=d5599e1148 href="http://www.ncbi.nlm.nih.gov/pubmed/29396010">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1151 href="https://doi.org/10.1016/S1473-3099(18)30066-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732604977">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d5599e1164 class=n-a></a>World Health Organization: Global technical strategy for malaria 2016-2030. World Health Organization. 2015‎. <a target=xrefwindow id=d5599e1166 href="https://www.who.int/malaria/publications/atoz/9789241564991/en/">Reference Source</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736337650"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1175 class=n-a></a>Conrad MD, Rosenthal PJ: Antimalarial drug resistance in Africa: the calm before the storm? <i>Lancet Infect Dis.</i> 2019; <b>19</b>(10): e338–e351. <a target=xrefwindow id=d5599e1183 href="http://www.ncbi.nlm.nih.gov/pubmed/31375467">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1186 href="https://doi.org/10.1016/S1473-3099(19)30261-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736337650">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d5599e1199 class=n-a></a>Deutsch-Feldman M, Aydemir O, Carrel M, <i> et al.</i>: The changing landscape of <i>Plasmodium falciparum</i> drug resistance in the Democratic Republic of Congo. <i>BMC Infect Dis.</i> 2019; <b>19</b>(1): 872. <a target=xrefwindow id=d5599e1213 href="http://www.ncbi.nlm.nih.gov/pubmed/31640574">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1217 href="https://doi.org/10.1186/s12879-019-4523-0">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1220 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6805465">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d5599e1230 class=n-a></a>Balikagala B, Mita T, Ikeda M, <i> et al.</i>: Absence of <i>in vivo</i> selection for K13 mutations after artemether–lumefantrine treatment in Uganda. <i>Malar J.</i> 2017; <b>16</b>(1): 23. <a target=xrefwindow id=d5599e1244 href="http://www.ncbi.nlm.nih.gov/pubmed/28068997">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1248 href="https://doi.org/10.1186/s12936-016-1663-1">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1251 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5223472">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d5599e1260 class=n-a></a>Mustapha MM, Harrison LH: Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges. <i>Hum Vaccin Immunother.</i> 2018; <b>14</b>(5): 1107–1115. <a target=xrefwindow id=d5599e1268 href="http://www.ncbi.nlm.nih.gov/pubmed/29211624">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1271 href="https://doi.org/10.1080/21645515.2017.1412020">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1274 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5989898">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d5599e1283 class=n-a></a>Ota MOC, Odutola AA, Owiafe PK, <i> et al.</i>: Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants. <i>Sci Transl Med.</i> 2011; <b>3</b>(88): 88ra56. <a target=xrefwindow id=d5599e1294 href="http://www.ncbi.nlm.nih.gov/pubmed/21697532">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1297 href="https://doi.org/10.1126/scitranslmed.3002461">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d5599e1306 class=n-a></a>Mensah VA, Roetynck S, Kanteh EK, <i> et al.</i>: Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial. <i>Front Immunol.</i> 2017; <b>8</b>: 1551. <a target=xrefwindow id=d5599e1317 href="http://www.ncbi.nlm.nih.gov/pubmed/29213269">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1320 href="https://doi.org/10.3389/fimmu.2017.01551">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1324 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5702785">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736423511"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1333 class=n-a></a>Dobaño C, Ubillos I, Jairoce C, <i> et al.</i>: RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated <i>Plasmodium falciparum</i> antigens associated with protection against clinical malaria in African children: a case-control study. <i>BMC Med.</i> 2019; <b>17</b>(1): 157. <a target=xrefwindow id=d5599e1347 href="http://www.ncbi.nlm.nih.gov/pubmed/31409398">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1351 href="https://doi.org/10.1186/s12916-019-1378-6">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1354 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6693200">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736423511">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735603359"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1367 class=n-a></a>Guerra Mendoza Y, Garric E, Leach A, <i> et al.</i>: Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa. <i>Hum Vaccin Immunother.</i> 2019; <b>15</b>(10): 2386–2398. <a target=xrefwindow id=d5599e1378 href="http://www.ncbi.nlm.nih.gov/pubmed/31012786">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1381 href="https://doi.org/10.1080/21645515.2019.1586040">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1385 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6816384">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735603359">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d5599e1399 class=n-a></a>Galactionova K, Tediosi F, Camponovo F, <i> et al.</i>: Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa. <i>Vaccine.</i> 2017; <b>35</b>(1): 53–60. <a target=xrefwindow id=d5599e1410 href="http://www.ncbi.nlm.nih.gov/pubmed/27890400">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1413 href="https://doi.org/10.1016/j.vaccine.2016.11.042">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726472002"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1422 class=n-a></a>Klein SL, Shann F, Moss WJ, <i> et al.</i>: RTS,S Malaria Vaccine and Increased Mortality in Girls. <i>mBio.</i> 2016; <b>7</b>(2): e00514–16. <a target=xrefwindow id=d5599e1433 href="http://www.ncbi.nlm.nih.gov/pubmed/27118593">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1436 href="https://doi.org/10.1128/mBio.00514-16">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1440 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4850267">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726472002">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d5599e1453 class=n-a></a>Giefing-Kröll C, Berger P, Lepperdinger G, <i> et al.</i>: How sex and age affect immune responses, susceptibility to infections, and response to vaccination. <i>Aging Cell.</i> 2015; <b>14</b>(3): 309–21. <a target=xrefwindow id=d5599e1464 href="http://www.ncbi.nlm.nih.gov/pubmed/25720438">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1467 href="https://doi.org/10.1111/acel.12326">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1471 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4406660">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d5599e1480 class=n-a></a>Flanagan KL, Fink AL, Plebanski M, <i> et al.</i>: Sex and Gender Differences in the Outcomes of Vaccination over the Life Course. <i>Annu Rev Cell Dev Biol.</i> 2017; <b>33</b>: 577–599. <a target=xrefwindow id=d5599e1491 href="http://www.ncbi.nlm.nih.gov/pubmed/28992436">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1494 href="https://doi.org/10.1146/annurev-cellbio-100616-060718">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736891831"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1503 class=n-a></a>Good MF, Stanisic DI: Whole parasite vaccines for the asexual blood stages of Plasmodium. <i>Immunol Rev.</i> 2020; <b>293</b>(1): 270–282. <a target=xrefwindow id=d5599e1511 href="http://www.ncbi.nlm.nih.gov/pubmed/31709558">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1514 href="https://doi.org/10.1111/imr.12819">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736891831">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d5599e1527 class=n-a></a>Davies DH, Duffy P, Bodmer JL, <i> et al.</i>: Large screen approaches to identify novel malaria vaccine candidates. <i>Vaccine.</i> 2015; <b>33</b>(52): 7496–505. <a target=xrefwindow id=d5599e1538 href="http://www.ncbi.nlm.nih.gov/pubmed/26428458">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1541 href="https://doi.org/10.1016/j.vaccine.2015.09.059">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1545 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4729565">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d5599e1555 class=n-a></a>Swearingen KE, Lindner SE, Shi L, <i> et al.</i>: Interrogating the <i>Plasmodium</i> Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics. <i>PLoS Pathog.</i> 2016; <b>12</b>(4): e1005606. <a target=xrefwindow id=d5599e1569 href="http://www.ncbi.nlm.nih.gov/pubmed/27128092">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1573 href="https://doi.org/10.1371/journal.ppat.1005606">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1576 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4851412">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d5599e1585 class=n-a></a>Bustamante LY, Powell GT, Lin Y-C, <i> et al.</i>: Synergistic malaria vaccine combinations identified by systematic antigen screening. <i>Proc Natl Acad Sci U S A.</i> 2017; <b>114</b>(45): 12045–12050. <a target=xrefwindow id=d5599e1596 href="http://www.ncbi.nlm.nih.gov/pubmed/29078270">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1599 href="https://doi.org/10.1073/pnas.1702944114">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1603 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5692528">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d5599e1612 class=n-a></a>Kanoi BN, Nagaoka H, Morita M, <i> et al.</i>: Comprehensive analysis of antibody responses to <i>Plasmodium falciparum</i> erythrocyte membrane protein 1 domains. <i>Vaccine.</i> 2018; <b>36</b>(45): 6826–6833. <a target=xrefwindow id=d5599e1626 href="http://www.ncbi.nlm.nih.gov/pubmed/30262245">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1630 href="https://doi.org/10.1016/j.vaccine.2018.08.058">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d5599e1639 class=n-a></a>Yagi M, Bang G, Tougan T, <i> et al.</i>: Protective epitopes of the <i>Plasmodium falciparum</i> SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences. <i>PLoS One.</i> 2014; <b>9</b>(6): e98460. <a target=xrefwindow id=d5599e1653 href="http://www.ncbi.nlm.nih.gov/pubmed/24886718">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1657 href="https://doi.org/10.1371/journal.pone.0098460">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1660 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4041889">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d5599e1669 class=n-a></a>Oyen D, Torres JL, Wille-Reece U, <i> et al.</i>: Structural basis for antibody recognition of the NANP repeats in <i>Plasmodium falciparum</i> circumsporozoite protein. <i>Proc Natl Acad Sci U S A.</i> 2017; <b>114</b>(48): E10438–E10445. <a target=xrefwindow id=d5599e1683 href="http://www.ncbi.nlm.nih.gov/pubmed/29138320">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1687 href="https://doi.org/10.1073/pnas.1715812114">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1690 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5715787">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732150119"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1699 class=n-a></a>Scally SW, Murugan R, Bosch A, <i> et al.</i>: Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection. <i>J Exp Med.</i> 2018; <b>215</b>(1): 63–75. <a target=xrefwindow id=d5599e1710 href="http://www.ncbi.nlm.nih.gov/pubmed/29167197">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1713 href="https://doi.org/10.1084/jem.20170869">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1717 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5748854">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732150119">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737042731"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1731 class=n-a></a>Doritchamou JY, Morrison R, Renn JP, <i> et al.</i>: Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some <i>Plasmodium falciparum</i> strains. <i>Commun Biol.</i> 2019; <b>2</b>: 457. <a target=xrefwindow id=d5599e1745 href="http://www.ncbi.nlm.nih.gov/pubmed/31840102">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1749 href="https://doi.org/10.1038/s42003-019-0704-z">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1752 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6897902">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737042731">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736034922"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1765 class=n-a></a>Rawlinson TA, Barber NM, Mohring F, <i> et al.</i>: Structural basis for inhibition of <i>Plasmodium vivax</i> invasion by a broadly neutralizing vaccine-induced human antibody. <i>Nat Microbiol.</i> 2019; <b>4</b>(9): 1497–507. <a target=xrefwindow id=d5599e1779 href="http://www.ncbi.nlm.nih.gov/pubmed/31133755">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1783 href="https://doi.org/10.1038/s41564-019-0462-1">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1786 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6711757">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736034922">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735842437"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1799 class=n-a></a>Urusova D, Carias L, Huang Y, <i> et al.</i>: Structural basis for neutralization of <i>Plasmodium vivax</i> by naturally acquired human antibodies that target DBP. <i>Nat Microbiol.</i> 2019; <b>4</b>(9): 1486–96. <a target=xrefwindow id=d5599e1813 href="http://www.ncbi.nlm.nih.gov/pubmed/31133752">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1817 href="https://doi.org/10.1038/s41564-019-0461-2">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1820 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6707876">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735842437">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d5599e1833 class=n-a></a>Whitacre DC, Espinosa DA, Peters CJ, <i> et al.</i>: <i>P. falciparum</i> and <i>P. vivax</i> Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections. <i>PLoS One.</i> 2015; <b>10</b>(5): e0124856. <a target=xrefwindow id=d5599e1851 href="http://www.ncbi.nlm.nih.gov/pubmed/25933001">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1854 href="https://doi.org/10.1371/journal.pone.0124856">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1857 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4416889">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d5599e1866 class=n-a></a>Ewer KJ, Lambe T, Rollier CS, <i> et al.</i>: Viral vectors as vaccine platforms: from immunogenicity to impact. <i>Curr Opin Immunol.</i> 2016; <b>41</b>: 47–54. <a target=xrefwindow id=d5599e1877 href="http://www.ncbi.nlm.nih.gov/pubmed/27286566">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1880 href="https://doi.org/10.1016/j.coi.2016.05.014">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d5599e1889 class=n-a></a>Janitzek CM, Matondo S, Thrane S, <i> et al.</i>: Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses. <i>Malar J.</i> 2016; <b>15</b>(1): 545. <a target=xrefwindow id=d5599e1900 href="http://www.ncbi.nlm.nih.gov/pubmed/27825348">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1903 href="https://doi.org/10.1186/s12936-016-1574-1">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1907 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5101663">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736915903"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1917 class=n-a></a>Yenkoidiok-Douti L, Williams AE, Canepa GE, <i> et al.</i>: Engineering a Virus-Like Particle as an Antigenic Platform for a Pfs47-Targeted Malaria Transmission-Blocking Vaccine. <i>Sci Rep.</i> 2019; <b>9</b>(1): 16833. <a target=xrefwindow id=d5599e1928 href="http://www.ncbi.nlm.nih.gov/pubmed/31727945">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1931 href="https://doi.org/10.1038/s41598-019-53208-z">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6856133">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736915903">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735412890"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e1948 class=n-a></a>Janitzek CM, Peabody J, Thrane S, <i> et al.</i>: A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine. <i>Sci Rep.</i> 2019; <b>9</b>(1): 5260. <a target=xrefwindow id=d5599e1959 href="http://www.ncbi.nlm.nih.gov/pubmed/30918267">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1962 href="https://doi.org/10.1038/s41598-019-41522-5">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1966 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6437161">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735412890">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d5599e1979 class=n-a></a>Leneghan DB, Miura K, Taylor IJ, <i> et al.</i>: Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines. <i>Sci Rep.</i> 2017; <b>7</b>(1): 3811. <a target=xrefwindow id=d5599e1990 href="http://www.ncbi.nlm.nih.gov/pubmed/28630474">PubMed Abstract </a> | <a target=xrefwindow id=d5599e1993 href="https://doi.org/10.1038/s41598-017-03798-3">Publisher Full Text </a> | <a target=xrefwindow id=d5599e1997 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5476561">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d5599e2006 class=n-a></a>Plotkin SA: Vaccines: correlates of vaccine-induced immunity. <i>Clin Infect Dis.</i> 2008; <b>47</b>(3): 401–9. <a target=xrefwindow id=d5599e2014 href="http://www.ncbi.nlm.nih.gov/pubmed/18558875">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2017 href="https://doi.org/10.1086/589862">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d5599e2026 class=n-a></a>van Els C, Mjaaland S, Næss L, <i> et al.</i>: Fast vaccine design and development based on correlates of protection (COPs). <i>Hum Vaccin Immunother.</i> 2014; <b>10</b>(7): 1935–48. <a target=xrefwindow id=d5599e2037 href="http://www.ncbi.nlm.nih.gov/pubmed/25424803">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2040 href="https://doi.org/10.4161/hv.28639">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2044 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4186026">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d5599e2053 class=n-a></a>McMahon BJ, Dentinger CM, Bruden D, <i> et al.</i>: Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. <i>J Infect Dis.</i> 2009; <b>200</b>(9): 1390–6. <a target=xrefwindow id=d5599e2064 href="http://www.ncbi.nlm.nih.gov/pubmed/19785526">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2067 href="https://doi.org/10.1086/606119">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d5599e2077 class=n-a></a>Li H, Li GJ, Chen QY, <i> et al.</i>: Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed? <i>Epidemiol Infect.</i> 2017; <b>145</b>(5): 887–94. <a target=xrefwindow id=d5599e2088 href="http://www.ncbi.nlm.nih.gov/pubmed/28065199">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2091 href="https://doi.org/10.1017/S0950268816003046">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d5599e2100 class=n-a></a>Simons BC, Spradling PR, Bruden DJ, <i> et al.</i>: A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen. <i>J Infect Dis.</i> 2016; <b>214</b>(2): 273–80. <a target=xrefwindow id=d5599e2111 href="http://www.ncbi.nlm.nih.gov/pubmed/27056956">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2114 href="https://doi.org/10.1093/infdis/jiw142">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2118 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4918827">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d5599e2127 class=n-a></a>Walker KM, Okitsu S, Porter DW, <i> et al.</i>: Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships. <i>Immunology.</i> 2015; <b>145</b>(1): 71–81. <a target=xrefwindow id=d5599e2138 href="http://www.ncbi.nlm.nih.gov/pubmed/25471322">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2141 href="https://doi.org/10.1111/imm.12428">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2145 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4405325">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d5599e2154 class=n-a></a>White MT, Verity R, Griffin JT, <i> et al.</i>: Immunogenicity of the RTS,S/AS01 Malaria Vaccine and Implications for Duration of Vaccine Efficacy: Secondary Analysis of Data From a Phase 3 Randomised Controlled Trial. <i>Lancet Infect Dis.</i> 2015; <b>15</b>(12): 1450–8. <a target=xrefwindow id=d5599e2165 href="http://www.ncbi.nlm.nih.gov/pubmed/26342424">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2168 href="https://doi.org/10.1016/S1473-3099(15)00239-X">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2172 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4655306">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d5599e2181 class=n-a></a>Regules JA, Cicatelli SB, Bennett JW, <i> et al.</i>: Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study. <i>J Infect Dis.</i> 2016; <b>214</b>(5): 762–71. <a target=xrefwindow id=d5599e2192 href="http://www.ncbi.nlm.nih.gov/pubmed/27296848">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2195 href="https://doi.org/10.1093/infdis/jiw237">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d5599e2204 class=n-a></a>Chaudhury S, Regules JA, Darko CA, <i> et al.</i>: Delayed Fractional Dose Regimen of the RTS,S/AS01 Malaria Vaccine Candidate Enhances an IgG4 Response That Inhibits Serum Opsonophagocytosis. <i>Sci Rep.</i> 2017; <b>7</b>(1): 7998. <a target=xrefwindow id=d5599e2215 href="http://www.ncbi.nlm.nih.gov/pubmed/28801554">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2218 href="https://doi.org/10.1038/s41598-017-08526-5">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2222 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5554171">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d5599e2232 class=n-a></a>White MT, Bejon P, Olotu A, <i> et al.</i>: The Relationship Between RTS,S Vaccine-Induced Antibodies, CD4<sup>+</sup> T Cell Responses and Protection Against <i>Plasmodium Falciparum</i> Infection. <i>PLoS One.</i> 2013; <b>8</b>(4): e61395. <a target=xrefwindow id=d5599e2250 href="http://www.ncbi.nlm.nih.gov/pubmed/23613845">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2253 href="https://doi.org/10.1371/journal.pone.0061395">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2256 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3628884">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731253673"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2265 class=n-a></a>Moris P, Jongert E, van der Most RG: Characterization of T-cell Immune Responses in Clinical Trials of the Candidate RTS,S Malaria Vaccine. <i>Hum Vaccin Immunother.</i> 2018; <b>14</b>(1): 17–27. <a target=xrefwindow id=d5599e2273 href="http://www.ncbi.nlm.nih.gov/pubmed/28934066">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2276 href="https://doi.org/10.1080/21645515.2017.1381809">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2279 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5791571">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731253673">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735573538"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2292 class=n-a></a>Jongo SA, Church LWP, Mtoro AT, <i> et al.</i>: Safety and Differential Antibody and T-Cell Responses to the <i>Plasmodium falciparum</i> Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants. <i>Am J Trop Med Hyg.</i> 2019; <b>100</b>(6): 1433–44. <a target=xrefwindow id=d5599e2306 href="http://www.ncbi.nlm.nih.gov/pubmed/30994090">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2310 href="https://doi.org/10.4269/ajtmh.18-0835">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2313 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6553883">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735573538">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d5599e2326 class=n-a></a>Theisen M, Adu B, Mordmüller B, <i> et al.</i>: The GMZ2 Malaria Vaccine: From Concept to Efficacy in Humans. <i>Expert Rev Vaccines.</i> 2017; <b>16</b>(9): 907–17. <a target=xrefwindow id=d5599e2337 href="http://www.ncbi.nlm.nih.gov/pubmed/28699823">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2340 href="https://doi.org/10.1080/14760584.2017.1355246">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736721309"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2349 class=n-a></a>Chaudhury S, Duncan EH, Atre T, <i> et al.</i>: Combining Immunoprofiling With Machine Learning to Assess the Effects of Adjuvant Formulation on Human Vaccine-Induced Immunity. <i>Hum Vaccin Immunother.</i> 2020; <b>16</b>(2): 400–11. <a target=xrefwindow id=d5599e2360 href="http://www.ncbi.nlm.nih.gov/pubmed/31589550">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2363 href="https://doi.org/10.1080/21645515.2019.1654807">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2367 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7062453">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736721309">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d5599e2380 class=n-a></a>Kazmin D, Nakaya HI, Lee EK, <i> et al.</i>: Systems Analysis of Protective Immune Responses to RTS,S Malaria Vaccination in Humans. <i>Proc Natl Acad Sci U S A.</i> 2017; <b>114</b>(9): 2425–30. <a target=xrefwindow id=d5599e2391 href="http://www.ncbi.nlm.nih.gov/pubmed/28193898">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2394 href="https://doi.org/10.1073/pnas.1621489114">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2398 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5338562">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d5599e2408 class=n-a></a>McIntosh EDG, Bröker M, Wassil J, <i> et al.</i>: Serum Bactericidal Antibody Assays - The Role of Complement in Infection and Immunity. <i>Vaccine.</i> 2015; <b>33</b>(36): 4414–21. <a target=xrefwindow id=d5599e2419 href="http://www.ncbi.nlm.nih.gov/pubmed/26187262">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2422 href="https://doi.org/10.1016/j.vaccine.2015.07.019">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d5599e2431 class=n-a></a>Mosley JF, Smith LL, Brantley P, <i> et al.</i>: Vaxchora: The First FDA-Approved Cholera Vaccination in the United States. <i>P T.</i> 2017; <b>42</b>(10): 638–40. <a target=xrefwindow id=d5599e2442 href="http://www.ncbi.nlm.nih.gov/pubmed/29018300">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2445 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5614415">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737698123"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2454 class=n-a></a>Saluja T, Mogasale VV, Excler JL, <i> et al.</i>: An overview of Vaxchora<sup>TM</sup>, a live attenuated oral cholera vaccine. <i>Hum Vaccin Immunother.</i> 2020; <b>16</b>(1): 42–50. <a target=xrefwindow id=d5599e2468 href="http://www.ncbi.nlm.nih.gov/pubmed/31339792">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2472 href="https://doi.org/10.1080/21645515.2019.1644882">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2475 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7012186">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737698123">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734512379"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2488 class=n-a></a>Roestenberg M, Kamerling IMC, de Visser SJ: Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development. <i>Front Med (Lausanne).</i> 2018; <b>5</b>: 297. <a target=xrefwindow id=d5599e2496 href="http://www.ncbi.nlm.nih.gov/pubmed/30420951">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2499 href="https://doi.org/10.3389/fmed.2018.00297">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2502 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6215823">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734512379">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731246289"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2515 class=n-a></a>Stanisic DI, McCarthy JS, Good MF: Controlled Human Malaria Infection: Applications, Advances, and Challenges. <i>Infect Immun.</i> 2018; <b>86</b>(1): pii: e00479-17. <a target=xrefwindow id=d5599e2523 href="http://www.ncbi.nlm.nih.gov/pubmed/28923897">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2526 href="https://doi.org/10.1128/IAI.00479-17">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2529 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5736798">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731246289">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732592221"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2542 class=n-a></a>Collins KA, Wang CY, Adams M, <i> et al.</i>: A controlled human malaria infection model enabling evaluation of transmission-blocking interventions. <i>J Clin Invest.</i> 2018; <b>128</b>(4): 1551–1562. <a target=xrefwindow id=d5599e2553 href="http://www.ncbi.nlm.nih.gov/pubmed/29389671">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2556 href="https://doi.org/10.1172/JCI98012">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2560 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5873858">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732592221">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d5599e2574 class=n-a></a>Mordmüller B, Surat G, Lagler H, <i> et al.</i>: Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. <i>Nature.</i> 2017; <b>542</b>(7642): 445–449. <a target=xrefwindow id=d5599e2585 href="http://www.ncbi.nlm.nih.gov/pubmed/28199305">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2588 href="https://doi.org/10.1038/nature21060">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d5599e2597 class=n-a></a>Schats R, Bijker EM, van Gemert GJ, <i> et al.</i>: Heterologous Protection against Malaria after Immunization with <i>Plasmodium falciparum</i> Sporozoites. <i>PLoS One.</i> 2015; <b>10</b>(5): e0124243. <a target=xrefwindow id=d5599e2611 href="http://www.ncbi.nlm.nih.gov/pubmed/25933168">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2615 href="https://doi.org/10.1371/journal.pone.0124243">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2618 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4416703">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727331397"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2627 class=n-a></a>Lyke KE, Ishizuka AS, Berry AA, <i> et al.</i>: Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. <i>Proc Natl Acad Sci U S A.</i> 2017; <b>114</b>(10): 2711–2716. <a target=xrefwindow id=d5599e2638 href="http://www.ncbi.nlm.nih.gov/pubmed/28223498">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2641 href="https://doi.org/10.1073/pnas.1615324114">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2645 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5347610">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727331397">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d5599e2658 class=n-a></a>Arévalo-Herrera M, Vásquez-Jiménez JM, Lopez-Perez M, <i> et al.</i>: Protective Efficacy of <i>Plasmodium vivax</i> Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial. <i>PLoS Negl Trop Dis.</i> 2016; <b>10</b>(10): e0005070. <a target=xrefwindow id=d5599e2672 href="http://www.ncbi.nlm.nih.gov/pubmed/27760143">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2676 href="https://doi.org/10.1371/journal.pntd.0005070">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2679 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5070852">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734959174"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2688 class=n-a></a>van den Hoogen LL, Walk J, Oulton T, <i> et al.</i>: Antibody Responses to Antigenic Targets of Recent Exposure Are Associated With Low-Density Parasitemia in Controlled Human <i>Plasmodium falciparum</i> Infections. <i>Front Microbiol.</i> 2019; <b>9</b>: 3300. <a target=xrefwindow id=d5599e2702 href="http://www.ncbi.nlm.nih.gov/pubmed/30700984">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2706 href="https://doi.org/10.3389/fmicb.2018.03300">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2709 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6343524">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734959174">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734655648"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2722 class=n-a></a>Dejon-Agobe JC, Ateba-Ngoa U, Lalremruata A, <i> et al.</i>: Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2. <i>Clin Infect Dis.</i> 2019; <b>69</b>(8): 1377–84. <a target=xrefwindow id=d5599e2733 href="http://www.ncbi.nlm.nih.gov/pubmed/30561539">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2736 href="https://doi.org/10.1093/cid/ciy1087">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2740 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6763635">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734655648">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d5599e2754 class=n-a></a>McCall MBB, Wammes LJ, Langenberg MC, <i> et al.</i>: Infectivity of <i>Plasmodium falciparum</i> sporozoites determines emerging parasitemia in infected volunteers. <i>Sci Transl Med.</i> 2017; <b>9</b>(395): pii: eaag2490. <a target=xrefwindow id=d5599e2768 href="http://www.ncbi.nlm.nih.gov/pubmed/28637923">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2772 href="https://doi.org/10.1126/scitranslmed.aag2490">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d5599e2781 class=n-a></a>Walk J, Reuling IJ, Behet MC, <i> et al.</i>: Modest heterologous protection after <i>Plasmodium falciparum</i> sporozoite immunization: a double-blind randomized controlled clinical trial. <i>BMC Med.</i> 2017; <b>15</b>(1): 168. <a target=xrefwindow id=d5599e2795 href="http://www.ncbi.nlm.nih.gov/pubmed/28903777">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2799 href="https://doi.org/10.1186/s12916-017-0923-4">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2802 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5598044">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733652328"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2811 class=n-a></a>Langenberg MCC, Wammes LJ, McCall MBB, <i> et al.</i>: Controlled Human Malaria Infection with Graded Numbers of <i>Plasmodium falciparum</i> NF135.C10- or NF166.C8-Infected Mosquitoes. <i>Am J Trop Med Hyg.</i> 2018; <b>99</b>(3): 709–12. <a target=xrefwindow id=d5599e2825 href="http://www.ncbi.nlm.nih.gov/pubmed/30014816">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2829 href="https://doi.org/10.4269/ajtmh.18-0194">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2832 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6169176">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733652328">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737181356"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2845 class=n-a></a>Moser KA, Drábek EF, Dwivedi A, <i> et al.</i>: Strains used in whole organism <i>Plasmodium falciparum</i> vaccine trials differ in genome structure, sequence, and immunogenic potential. <i>Genome Med.</i> 2020; <b>12</b>(1): 6. <a target=xrefwindow id=d5599e2859 href="http://www.ncbi.nlm.nih.gov/pubmed/31915075">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2863 href="https://doi.org/10.1186/s13073-019-0708-9">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2866 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6950926">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737181356">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d5599e2879 class=n-a></a>Chattopadhyay R, Pratt D: Role of controlled human malaria infection (CHMI) in malaria vaccine development: A U.S. food &amp; drug administration (FDA) perspective. <i>Vaccine.</i> 2017; <b>35</b>(21): 2767–9. <a target=xrefwindow id=d5599e2887 href="http://www.ncbi.nlm.nih.gov/pubmed/28431816">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2890 href="https://doi.org/10.1016/j.vaccine.2017.03.072">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732587837"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2899 class=n-a></a>Good MF, Miller LH: Interpreting challenge data from early phase malaria blood stage vaccine trials. <i>Expert Rev Vaccines.</i> 2018; <b>17</b>(3): 189–96. <a target=xrefwindow id=d5599e2907 href="http://www.ncbi.nlm.nih.gov/pubmed/29382292">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2910 href="https://doi.org/10.1080/14760584.2018.1435278">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732587837">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d5599e2924 class=n-a></a>O'Connor D, Clutterbuck EA, Thompson AJ, <i> et al.</i>: High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. <i>Genome Med.</i> 2017; <b>9</b>(1): 11. <a target=xrefwindow id=d5599e2935 href="http://www.ncbi.nlm.nih.gov/pubmed/28137280">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2938 href="https://doi.org/10.1186/s13073-017-0400-x">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2942 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5282650">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d5599e2951 class=n-a></a>Palacpac NMQ, Ntege E, Yeka A, <i> et al.</i>: Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36. <i>PLoS One.</i> 2013; <b>8</b>(5): e64073. <a target=xrefwindow id=d5599e2962 href="http://www.ncbi.nlm.nih.gov/pubmed/23724021">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2965 href="https://doi.org/10.1371/journal.pone.0064073">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2969 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3665850">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732235071"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e2978 class=n-a></a>Ademolue TW, Awandare GA: Evaluating antidisease immunity to malaria and implications for vaccine design. <i>Immunology.</i> 2018; <b>153</b>(4): 423–34. <a target=xrefwindow id=d5599e2986 href="http://www.ncbi.nlm.nih.gov/pubmed/29211303">PubMed Abstract </a> | <a target=xrefwindow id=d5599e2989 href="https://doi.org/10.1111/imm.12877">Publisher Full Text </a> | <a target=xrefwindow id=d5599e2992 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5838420">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732235071">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732122956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e3005 class=n-a></a>Olotu A, Urbano V, Hamad A, <i> et al.</i>: Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men. <i>Am J Trop Med Hyg.</i> 2018; <b>98</b>(1): 308–18. <a target=xrefwindow id=d5599e3016 href="http://www.ncbi.nlm.nih.gov/pubmed/29141739">PubMed Abstract </a> | <a target=xrefwindow id=d5599e3019 href="https://doi.org/10.4269/ajtmh.17-0449">Publisher Full Text </a> | <a target=xrefwindow id=d5599e3023 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5928718">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732122956">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734916549"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e3036 class=n-a></a>Shanks GD: Tolerance May Be More Appropriate Than Immunity When Describing Chronic Malaria Infections. <i>Am J Trop Med Hyg.</i> 2019; <b>100</b>(3): 497–500. <a target=xrefwindow id=d5599e3044 href="http://www.ncbi.nlm.nih.gov/pubmed/30675843">PubMed Abstract </a> | <a target=xrefwindow id=d5599e3047 href="https://doi.org/10.4269/ajtmh.18-0906">Publisher Full Text </a> | <a target=xrefwindow id=d5599e3050 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6402920">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734916549">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d5599e3063 class=n-a></a>Yagi M, Palacpac NMQ, Ito K, <i> et al.</i>: Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda. <i>Sci Rep.</i> 2016; <b>6</b>: 34363. <a target=xrefwindow id=d5599e3074 href="http://www.ncbi.nlm.nih.gov/pubmed/27703240">PubMed Abstract </a> | <a target=xrefwindow id=d5599e3077 href="https://doi.org/10.1038/srep34363">Publisher Full Text </a> | <a target=xrefwindow id=d5599e3081 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5050508">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d5599e3091 class=n-a></a>Dicko A, Greenwood B: Malaria vaccination and rebound malaria. <i>Lancet Infect Dis.</i> 2019; <b>19</b>(8): 790–1. <a target=xrefwindow id=d5599e3099 href="http://www.ncbi.nlm.nih.gov/pubmed/31300332">PubMed Abstract </a> | <a target=xrefwindow id=d5599e3102 href="https://doi.org/10.1016/S1473-3099(19)30282-8">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736190761"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e3111 class=n-a></a>Tinto H, Otieno W, Gesase S, <i> et al.</i>: Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial. <i>Lancet Infect Dis.</i> 2019; <b>19</b>(8): 821–32. <a target=xrefwindow id=d5599e3122 href="http://www.ncbi.nlm.nih.gov/pubmed/31300331">PubMed Abstract </a> | <a target=xrefwindow id=d5599e3125 href="https://doi.org/10.1016/S1473-3099(19)30300-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736190761">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726470484"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e3138 class=n-a></a>Olotu A, Fegan G, Wambua J, <i> et al.</i>: Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children. <i>N Engl J Med.</i> 2016; <b>374</b>(26): 2519–29. <a target=xrefwindow id=d5599e3149 href="http://www.ncbi.nlm.nih.gov/pubmed/27355532">PubMed Abstract </a> | <a target=xrefwindow id=d5599e3152 href="https://doi.org/10.1056/NEJMoa1515257">Publisher Full Text </a> | <a target=xrefwindow id=d5599e3156 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4962898">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726470484">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d5599e3169 class=n-a></a>Palacpac NMQ, Tougan T, Horii T: Preclinical Studies on a New Vaccine Formulation of BK-SE36, a Malaria Vaccine Candidate. <i>Juntendo Medical Journal.</i> 2015; <b>61</b>(4): 360–9. <a target=xrefwindow id=d5599e3177 href="https://doi.org/10.14789/jmj.61.360">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d5599e3186 class=n-a></a>Didierlaurent AM, Laupèze B, Di Pasquale A, <i> et al.</i>: Adjuvant system AS01: helping to overcome the challenges of modern vaccines. <i>Expert Rev Vaccines.</i> 2017; <b>16</b>(1): 55–63. <a target=xrefwindow id=d5599e3197 href="http://www.ncbi.nlm.nih.gov/pubmed/27448771">PubMed Abstract </a> | <a target=xrefwindow id=d5599e3200 href="https://doi.org/10.1080/14760584.2016.1213632">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d5599e3209 class=n-a></a>Singh SK, Thrane S, Janitzek CM, <i> et al.</i>: Improving the malaria transmission-blocking activity of a <i>Plasmodium falciparum</i> 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display. <i>Vaccine.</i> 2017; <b>35</b>(30): 3726–32. <a target=xrefwindow id=d5599e3223 href="http://www.ncbi.nlm.nih.gov/pubmed/28578824">PubMed Abstract </a> | <a target=xrefwindow id=d5599e3227 href="https://doi.org/10.1016/j.vaccine.2017.05.054">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734840452"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5599e3237 class=n-a></a>Mordmüller B, Sulyok M, Egger-Adam D, <i> et al.</i>: First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria. <i>Clin Infect Dis.</i> 2019; <b>69</b>(9): 1509–16. <a target=xrefwindow id=d5599e3248 href="http://www.ncbi.nlm.nih.gov/pubmed/30629148">PubMed Abstract </a> | <a target=xrefwindow id=d5599e3251 href="https://doi.org/10.1093/cid/ciy1140">Publisher Full Text </a> | <a target=xrefwindow id=d5599e3255 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6792113">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734840452">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Apr 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-296.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-296.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan<br/> <p> <div class=margin-bottom> Nirianne Marie Q. Palacpac <br/> <span>Roles: </span> Conceptualization, Resources, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Toshihiro Horii <br/> <span>Roles: </span> Conceptualization, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-296/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 27 Apr 2020, 9:296 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.22143.1">https://doi.org/10.12688/f1000research.22143.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Palacpac NMQ and Horii T. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=24419 data-id=22143 data-downloads="" data-views="" data-scholar="10.12688/f1000research.22143.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-296/v1/pdf?article_uuid=71e47577-724a-45f1-87a5-9043e13ab52a" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.22143.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Palacpac NMQ and Horii T. Malaria vaccines: facing unknowns [version 1; peer review: 2 approved] <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):296 (<a href="https://doi.org/10.12688/f1000research.22143.1" target=_blank>https://doi.org/10.12688/f1000research.22143.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=22143 id=mobile-track-article-signin-22143 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/22143?target=/articles/9-296.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=24419 /> <input name=articleId type=hidden value=22143 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Patrick E Duffy</strong>, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Peter Kremsner</strong>, University of Tübingen, Germany </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Apr 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-296.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-296.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=37071-62555></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=66648-62554></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-296/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>27 Apr 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Patrick E Duffy</strong>, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Peter Kremsner</strong>, University of Tübingen, Germany </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-296.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-296/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Malaria vaccines: facing unknowns".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-296/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-296/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-296/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Palacpac NMQ and Horii T');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-296/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-296",
            templates : {
                twitter : "Malaria vaccines: facing unknowns. Palacpac NMQ and Horii T, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-296/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Malaria vaccines: facing unknowns", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Malaria vaccines: facing unknowns", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/22143/24419")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "24419");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "62554": 0,
                           "62555": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "bb5c1fb4-9c6b-4365-8cdf-08e02fa9d32f";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-296.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-296.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-296.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-296.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-296.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>